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Background. Pediatric patients with neoplastic diseases are more likely to develop nosocomial infections (NIs). NIs may prolong
their hospital stay, and increase morbidity and mortality. Objectives. The objectives of this study were to determine: (1) the
incidence of NIs, (2) sites of NIs, (3) causal organisms, and (4) outcomes of NIs among pediatric patients with neoplastic diseases.
Methods. This study was a prospective cohort study of pediatric patients with neoplastic diseases who were admitted to the Chiang
Mai University Hospital, Thailand. Results. A total of 707 pediatric patients with neoplastic diseases were admitted. Forty-six
episodes of NIs in 30 patients were reported (6.5 NIs/100 admission episodes and 7 NIs/1000 days of hospitalization). Patients
with acute lymphoblastic leukemia had the highest number of NIs (41.3%). The most common causal organisms were gram-
negative bacteria (47.1%). Patients who had undergone invasive procedures were more likely to develop NIs than those who had
not (P<. 05). The mortality rate of patients with NIs was 19.6%. Conclusion. Pediatric patients with neoplastic diseases are more
likely to develop NIs after having undergone invasive procedures. Pediatricians should be aware of this and strictly follow infection
control guidelines in order to reduce morbidity and mortality rates related to NIs.
Copyright © 2009 Peninnah Oberdorfer et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1.Introduction
The recent medical developments, including the increased
use of chemotherapy drugs, white blood cell stimulants, and
broad spectrum antibiotics, have improved the prognosis
and life span of pediatric patients with neoplastic diseases.
Consequently, these patients often face lengthy periods of
low immunity, undergo longer hospital stays, and there is a
greater chance that they will require central venous catheter-
izations, urinary catheterizations, endotracheal intubations,
and intravenous feeding tubes. These factors moreover put
patients at an increased risk of contracting nosocomial
infections (NIs) and substantially increase morbidity and
mortality rates as well as treatment costs [1–3].
Nosocomial infections in patients with malignancies can
be caused by bacteria, fungi, and viruses and can occur in
the bloodstream; urinary, respiratory, and digestive tracts; as
well as soft tissues [2] .T h ep r e v i o u ss t u d i e sh a v eb e e nd o n e
among both adult and pediatric patients with neoplastic
diseases reporting a high risk of NIs [4–7] and showing
incidence rates of NIs ranging from 1.08 to 1.77 times/100
days of hospitalization [8–11].
In addition, the previous studies among pediatric
patients with neoplastic diseases found that NIs were
associated with the use of devices [6–11]. For example, a
US surveillance among pediatric patients with neoplastic
diseases found that bacteremia occurred 6.6 times/1000 days
of central venous catheterization, urinary tract infections 4
times/1000 days of urinary catheterization, and pneumonia
2.9 times/1000 days of endotracheal intubation [7]. Causal
organisms related to NIs vary according to settings and
study populations. In Germany, Simon et al. identiﬁed
gram-positive bacteria as the common causal organism of
NIs (83.3%) among pediatric patients with central venous
catheterization [10]. In contrast, a study by Frank et al. in2 International Journal of Pediatrics
Israel found gram-negative bacteria (54.3%) more common
than gram-positive bacteria (36.6%) among children and
adolescents in intensive care settings [12].
Most NIs have a signiﬁcant eﬀect since they lengthen
hospital stays, increase mortality, and increase complications
[8–11]. At present, studies of NIs in pediatric patients with
neoplastic diseases are under reported in Thailand.
2.Objectives
To determine (1) the incidence of NIs among pediatric
patients with neoplastic diseases, (2) sites of NIs, (3) causal
organisms, and (4) outcomes of NIs.
3. Methods
3.1. Patients and Setting. The study was conducted in the
32-bed pediatric hematology/oncology ward of the Chiang
Mai University Hospital, Chiang Mai, Thailand. Patients in
this ward are up to 15 years old and all have neoplastic
diseases.Thepatientsreceivedchemotherapyregimensbased
on recommendations by the Thai Pediatric Oncology Group.
Antibiotic and antifungal prophylaxes are not routinely
provided. We excluded those patients who (1) had fever of
unknownorigin,sincewecouldnotﬁndanyotherclinicalor
radiological signs of infection as well as isolate any causative
organisms and therefore could not classify them as having
an NI with certainty, (2) received any antibiotic prophylaxis,
and (3) had viral-related illness diagnosed by clinicians.
3.2. Surveillance Procedures of NIs and Case Deﬁnitions. We
conductedaprospectivecohortstudyduringDecember2005
and May 2006. The clinical symptoms of each patient were
monitored daily from admission until hospital discharge
by pediatricians and nurses. Data were obtained from
medical records and nurse notes. The ﬁndings were recorded
during admission on a data extraction form that included
demographicdata,dischargediagnoses,intrinsicriskfactors,
extrinsic risk factors, causal organisms, and treatment out-
comes. The deﬁnitions for NIs were based on the criteria
outlined by the US Centers for Disease Control and Preven-
tion in 2004 [13]. Neoplastic diseases in pediatric patients
were classiﬁed as follows: hematologic neoplasia (acute lym-
phoblastic leukemia (ALL), acute myeloid leukemia (AML),
non-Hodgkin’s lymphoma, Hodgkin’s disease), solid tumors
(bone tumors, rhadomyosarcoma, central nervous system
tumors, neuroblastoma, and Wilm’s tumor), and others
(Schwanoma, hepatoblastoma, and lymphangioma).
3.3. Analysis of Data. The data were analyzed by calculating
NI rates per 1000 days of hospitalization and per 100
admittances. The relationship between NI rates and various
extrinsic factors was analyzed using a chi-square test when
there was a need to compare proportional data, using a level
of 95% conﬁdence interval.
4. Results
4.1. Population Characteristics. W ec o l l e c t e dd a t ao f7 0 7
admissions (6561 days of hospitalization) during the study
period (Table 1). Fifty-four percent were males with a mean
age of 6.9 years (range: 3 months–15 years; SD = 4y e a r s ) .
The most common neoplastic disease on admission was
ALL(59%). Eighty-seven percentofpatients had leukopenia,
52.2% had an absolute neutrophil count of less than
500/mm3, and 58.7% had thrombocytopenia.
4.2. Rates of NIs. Nosocomial infections were reported
among 46 admissions (6.5/100 admission episodes; 7
episodes/1000 days of hospitalization). There were 13
episodes of urinary tract infections per 1000 days of urinary
catheterization, 21 episodes of pneumonia per 1000 days
of endotrachial intubation, and no episodes of bacteremia
among patients who had central venous catheterization.
EpisodesofNIsweremostfrequentamongpatientswithALL
(41.3%), and patients with AML (34.8%).
4.3. Sites of NIs. T h em o s tc o m m o ns i t e so fN I sw e r e
the blood stream (30.5%) and the ear/nose/throat (19.6%)
(Table 2).
4.4. Causal Organisms of NIs. Causal organisms of NIs were
identiﬁed in 34 episodes (73.9%). The most common were
gram-negative bacteria (47.1%), followed by gram-positive
bacteria (29.4%), and fungi (14.7%) (Table 3).
4.5. Procedures Related to NIs. Patients who developed NIs
were more likely to have had endotracheal intubation (mean
duration: 10.2 days; range: 1–15 days), urinary catheteriza-
tion (mean duration: 5.8 days; range: 1–10 days), nasogastric
tube(meanduration:4.9days;range:1–17days),andcentral
venous catheterization (mean duration: 1.7 days; range: 1-2
days) (P<. 001) (Table 4).
4.6. Outcomes of NIs. The mean time from admittance until
time of diagnosis of an NI was 22 days (range: 2–126 days;
SD: 23 days). The majority of NIs (74%) occurred between
the 2nd and the 30th day of hospitalization.
Nine patients died (19.6%): 4 with ALL (44.4%), 4 with
AML (44.4%), and 1 with an astrocytoma brain tumor.
Four patients (44.4%) had bacteremia, 3 (33.4%) had soft
tissue infections, 1 (11.1%) had pneumonia, and 1 had both
bacteremia and pneumonia. Three patients (33.4%) were
infected with gram-positive bacteria, 2 (22.2%) with gram-
negative bacteria, 2 (22.2%) with fungal organisms, and 1
patient (11.1%) was found to be infected with gram-positive
bacteria and a fungal organism.
5. Discussion
A total of 707 admission episodes were included in the study.
Forty-six episodes of NIs were reported (the incidence of
NIs was 6.5/100 admission episodes; 7 episodes/1000 days
of hospitalization). A previous study of pediatric patientsInternational Journal of Pediatrics 3
Table 1: Demographic characteristics of study samples.
Demographic characteristics Number of admissions (%) (N = 707) Number NIs (%) (N = 46)
Gender and age
Male : Female 380 (53.7) : 327 (46.3) 27 (58.7) : 19 (41.3)
Mean age (years) ±SD 6.88 ±46 .97 ±4.92
Underlying diseases
Hematologic neoplasia
Acute lymphoblastic leukemia 417 (59.0) 19 (41.3)
Acute myeloblastic leukemia 59 (8.4) 16 (34.8)
Non-Hodgkin lymphoma 27 (3.8) 1 (2.2)
Hodgkin disease 11 (1.6) 1 (2.2)
Chronic myeloid leukemia 11 (1.6) —
Solid tumor
Bone tumor
Osteosarcoma 31 (4.4) 1 (2.2)
Ewing’s sarcoma 25 (3.5) —
Neuroblastoma 29 (4.1) —
Hepatoblastoma 14 (2.0) —
Retinoblastoma 14 (2.0) —
Rhabdomyosarcoma 13 (1.8) —
Wilm tumor 10 (1.4) 1 (2.2)
Hepatoma 7 (1.0) —
Germ cell tumor 5 (0.7) 1 (2.2)
CNS tumor+ 34 (4.8) 6 (13.1)
+: Astrocytoma, Medulloblastoma, Medulloepithelioma, Ependymoma.
Table 2: Types of nosocomial infections.
Types of NIs Total Number of
NIs (%) (N = 46)
Associated
procedures
(N = 32)
Blood stream 14 (30.5) ET (5), U (5), C (2)
Ear/nose/throat 9 (19.6) NG (9)
Soft tissue 6 (13.1) —
Gastrointestinal tract 6 (13.1) NG (2)
Urinary tract 5 (10.9) U (5)
Pneumonia 4 (8.7) ET (4)
Surgical site 1 (2.2) —
Meningitis 1 (2.2) —
ET: endotracheal intubation; U: urinary catheterization; NG: nasogastric
tube; C: central venous catheterization.
with neoplastic diseases in Germany by Simon et al. [10]
found a rate of NIs of 5.2 cases per 100 admittances and
of 10.8 cases per 1000 days of hospitalization, which is
similar to the results obtained by our study. A study of
Urrea et al. [11] among pediatric patients with neoplastic
diseases in Spain found an NI rate of 1.77 cases per 100
days of hospitalization. The incidence of NIs in our study
was relatively low in comparison to the study of Urrea et al.
This may be because our study excluded patients with fever
of unknown origin and those who had viral infections. In
addition, in our study patients appeared to have lower rates
of central venous catheterizations than patients in previous
studies[5,10,11].PatientswithALLwhorepresented59%of
thesamplepopulationhadthehighestNIrate(41.3%)inour
study. Since the percentage of ALL patients in our study was
higher than that reported in other studies [10, 11], it could
represent a skewed population.
In regards to sites of NIs, most infections in our study
occurred in the blood stream (30.5%), as in other studies
by Simon et al. [10] (52.5%) and Urrea et al. [11] (55.5%).
Regarding causal organisms of NIs, studies from Eastern
countries found that gram-negative bacteria were most
common, like in our study. Our study found 47.1% gram-
negative bacteria and 29.4% gram-positive bacteria while
the study by Frank et al. [12] in Israel from 1992 to 2001,
which focused particularly on bacteremia in pediatric wards,
found 54.3% gram-negative bacteria and 36.6% gram-
positive bacteria. However, our study focused on children
with neoplastic diseases while Frank’s et al. study included
the general pediatric population, including intensive care
units. Therefore this comparison might not be completely
valid. In contrast, studies from European countries were
more likely to report gram-positive bacteria to be more
common. For example, the study by Simon et al. [10]
found up to 83.3% gram-positive and 11.1% gram-negative
bacteria, and the study by Urrea et al. [11]r e p o r t e du p
to 78.6% gram-positive bacteria. The higher rate of gram-
positive bacteria as causal organisms for NIs in European4 International Journal of Pediatrics
Table 3: Causal organisms of nosocomial infections.
Causal organisms Number (%)
(N = 34)
Gram-negative organisms 16 (47.1)
Escherichia coli 3 (8.8)
Klebsiella pneumonia 3 (8.8)
Salmonella enteritidis 3 (8.8)
Pseudomonas aeruginosa 2 (5.9)
Others+ 5 (2.9)
Gram-positive organisms 10 (29.4)
Staphylococcus aureus 5 (14.7)
Coagulase negative Staphylococcus 4 (11.8)
Enterococcus fecium 1 (2.9)
Fungi 5 (14.7)
Candida albicans 3 (8.8)
Candida tropicalis 2 (5.8)
Co-organisms 3 (8.8)
Enterococcus fecium +C o a g u l a s en e g a t i v e
Staphylococcus 2 (5.9)
Enterococcus fecium +Escherichia coli 1 (2.9)
+: Acinetobactor baumanii, Aeromonas, Burkholderia cepacia, Enterobactor
cloacae, Hemophilus inﬂuenza.
Table 4: Comparison of procedures related to nosocomial infec-
tions.
Procedures NIs (%)
(total = 46)
Non-NIs (%)
(total = 661)
P-value
Endotracheal intubation 9 (19.6) 3 (0.4) P<. 001
Urinary catheterization 10 (21.7) 6 (0.9) P<. 001
Nasogastric tube 11 (23.9) 6 (0.9) P<. 001
Central venous
catheterization 2 (4.3) 0 (0) P<. 001
countries could be due to the fact that in European countries
central venous catheterization is more common than in
Eastern countries, such as in Thailand. In addition, in our
study we found 3 cases of Salmonella enteritidis infections.
Salmonella enteritidis is unlikely to be a causal organism of
NIs since it is normally found in community settings. We
think that these patients may have been colonized with this
organism outside the hospital and then developed symptoms
when their immunity level was low after chemotherapy.
Furthermore, our study found that fungal infections
accounted for 14.7% of infections, while in the previous
two studies by Simon et al. [10]a n dU r r e ae ta l .[ 11]n o
fungal infections were found among pediatric patients with
neoplastic diseases. However, in the Israeli study, fungal
infections also occurred, most of which were bloodstream
infections.Therefore,amongpediatricpatientswithneoplas-
tic diseases who suﬀer from a low white blood cell count for
a long period of time, care should be taken to guard against
fungal infections as well.
Concerning procedures that can make patients vulner-
able to NIs, we found that endotracheal intubation, naso-
gastric tube insertion, urinary catheterization and central
venous catheterization signiﬁcantly increased the incidence
of NIs (P-value < .001). Patients who were exposed to more
invasive procedures such as endotracheal intubation (mean
duration: 4.9 days) and central venous catheterization (mean
duration: 1.7 days) also more quickly developed NIs than
patients who were exposed to less invasive procedures such
as nasogastric tube insertion (mean duration: 10.2 days).
We therefore recommend that the more invasive procedures
should be carried out only when necessary in order to reduce
the incidence of NIs.
The strengths of our study are twofold. First, it is
a prospective study in which NI episodes were carefully
monitored and the data collection carried out according
to a given research plan. Second, according to our best
knowledge,itistheﬁrststudyofNIepisodesamongpediatric
patients with neoplastic diseases in Thailand.
However, our study also has the following limitations.
First, the period of data collection was relatively short. A
longer period of data collection would be able to provide
a clearer picture of NI episodes among this group. Second,
care should be taken when comparing the incidence rates
of NIs of our study with those of other institutions and
countries, since we have excluded patients who had fever of
unknown origin and viral related illnesses. These entities are
computed in most studies as NIs per CDC criteria. Third, we
also have not recorded the types of chemotherapy regimens
these patients received as well as their cancer stages, which
may have some impact on episodes of NIs. Further studies
could address these shortcomings. Fourth, our study also did
not investigate the relationship between the incidence of NIs
and other intrinsic factors, including the presence of other
underlyingdiseasesaswellaslevelofanemiaandwhiteblood
cell counts.
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